Johnston, Robert J.
Su, Linhui Julie
Pinckney, Jason
Critton, David
Boyer, Eric
Krishnakumar, Arathi
Corbett, Martin
Rankin, Andrew L.
Dibella, Rose
Campbell, Lynne
Martin, Gaelle H.
Lemar, Hadia
Cayton, Thomas
Huang, Richard Y.-C.
Deng, Xiaodi
Nayeem, Akbar
Chen, Haibin
Ergel, Burce
Rizzo, Joseph M.
Yamniuk, Aaron P.
Dutta, Sanjib
Ngo, Justine
Shorts, Andrea Olga
Ramakrishnan, Radha
Kozhich, Alexander
Holloway, Jim
Fang, Hua
Wang, Ying-Kai
Yang, Zheng
Thiam, Kader
Rakestraw, Ginger
Rajpal, Arvind
Sheppard, Paul
Quigley, Michael
Bahjat, Keith S.
Korman, Alan J.
Article History
Received: 25 October 2018
Accepted: 20 September 2019
First Online: 23 October 2019
Competing interests
: All authors are or were employees of the companies Bristol-Myers Squibb, Five Prime Therapeutics, and genOway, which develop drugs and research models for profit.